Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
ISLAMABAD: The government on Wednesday announced that it was introducing an optional multi-tariff time of use (ToU) mechanism for industrial consumers for optimal utilisation of grid supply through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results